Literature DB >> 2239909

The prevalence of Chlamydia trachomatis infection among mothers of children with trachoma.

R C Brunham1, M Laga, J N Simonsen, D W Cameron, R Peeling, J McDowell, H Pamba, J O Ndinya-Achola, G Maitha, F A Plummer.   

Abstract

The authors studied the epidemiology of Chlamydia trachomatis infection in a trachoma-endemic area of central Kenya. Children with abnormal ocular discharge were evaluated for clinical evidence of trachoma and were cultured for C. trachomatis. Isolated strains of C. trachomatis were immunotyped with monoclonal antibodies. Overall, 221 children from 207 families were evaluated. Clinically, 91 children (41%) had trachomatous follicular inflammation, and 130 (59%) had papillary hypertrophy without visible follicle and were labeled as having mucopurulent conjunctivitis. C. trachomatis was isolated from 31 of 91 children with trachoma (34%) and 17 of 130 children with conjunctivitis (13%) (p less than 0.001). Twenty-two C. trachomatis strains were immunotyped: 17 were from children with trachoma (nine type A, one A/L2, five B, one Ba, and one E) and five were from children with conjunctivitis (two A, one Ba, one D, and one F). A total of 168 mothers were evaluated for cervical C. trachomatis infection, and seven (4%) were culture-positive. Two strains were immunotyped as serovar E. The authors conclude that C. trachomatis ocular infections are due to heterogeneous serovars in this area, that most cases of trachoma are due to C. trachomatis infection with the classic trachoma serovars (A, B, or Ba), and that cervical C. trachomatis infection is uncommon among mothers of children with trachoma.

Entities:  

Mesh:

Year:  1990        PMID: 2239909     DOI: 10.1093/oxfordjournals.aje.a115737

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  8 in total

1.  Late-stage inclusion body conjunctivitis: trachoma?

Authors:  Martin Zinkernagel; Elena Catalano; Dagmar Ammann-Rauch
Journal:  Br J Ophthalmol       Date:  2007-03       Impact factor: 4.638

2.  Use of PCR and reverse line blot hybridization assay for rapid simultaneous detection and serovar identification of Chlamydia trachomatis.

Authors:  Likuan Xiong; Fanrong Kong; Hua Zhou; Gwendolyn L Gilbert
Journal:  J Clin Microbiol       Date:  2006-04       Impact factor: 5.948

3.  Maternal immunity partially protects newborn mice against a Chlamydia trachomatis intranasal challenge.

Authors:  Sukumar Pal; Olga Tatarenkova; Luis M de la Maza
Journal:  J Reprod Immunol       Date:  2010-06-15       Impact factor: 4.054

4.  Chlamydia-infected cells continue to undergo mitosis and resist induction of apoptosis.

Authors:  Whitney Greene; Yangming Xiao; Yanqing Huang; Grant McClarty; Guangming Zhong
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

Review 5.  Diagnosis and assessment of trachoma.

Authors:  Anthony W Solomon; Rosanna W Peeling; Allen Foster; David C W Mabey
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

6.  Randomised equivalency trial comparing 2.5% povidone-iodine eye drops and ophthalmic chloramphenicol for preventing neonatal conjunctivitis in a trachoma endemic area in southern Mexico.

Authors:  Marco A Ramirez-Ortiz; Manuel Rodriguez-Almaraz; Héctor Ochoa-Diazlopez; Paulina Diaz-Prieto; Romeo S Rodriguez-Suárez
Journal:  Br J Ophthalmol       Date:  2007-11       Impact factor: 4.638

7.  Mechanism of T-cell mediated protection in newborn mice against a Chlamydia infection.

Authors:  Sukumar Pal; Luis M de la Maza
Journal:  Microbes Infect       Date:  2013-05-02       Impact factor: 2.700

Review 8.  Epidemiology and control of trachoma: systematic review.

Authors:  Victor H Hu; Emma M Harding-Esch; Matthew J Burton; Robin L Bailey; Julbert Kadimpeul; David C W Mabey
Journal:  Trop Med Int Health       Date:  2010-04-04       Impact factor: 2.622

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.